Harold Bernstein

President, R&D & CMO, Maze Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$9.5M

Companies

Latest trade

Oct 1, 2026

Companies

Maze Therapeutics, Inc.President, R&D & CMO −$9.5M

Trades

MAZE Sold 16,141 shares at $26.93 · planned $0.4M Oct 1

MAZE Sold 9,705 shares at $26.22 · planned $0.3M Sep 4

MAZE Sold 5,189 shares at $26.01 $0.1M Sep 3

MAZE Sold 5,106 shares at $26.47 $0.1M Sep 2

MAZE Sold 16,141 shares at $26.36 · planned $0.4M Sep 1

MAZE Sold 16,142 shares at $27.61 · planned $0.4M Aug 13

MAZE Sold 14,609 shares at $29.91 · planned $0.4M Jul 1

MAZE Sold 14,853 shares at $25.66 · planned $0.4M Jun 1

MAZE Sold 15,000 shares at $26.22 · planned $0.4M May 14

MAZE Sold 15,000 shares at $29.46 · planned $0.4M Apr 1

MAZE Sold 15,000 shares at $49.10 · planned $0.7M Mar 20

MAZE Sold 30,000 shares at $50.46 · planned $1.5M Mar 10

MAZE Sold 15,000 shares at $46.02 · planned $0.7M Feb 2

MAZE Sold 25,156 shares at $40.20 · planned $1.0M Jan 7

MAZE Sold 412 shares at $40.00 · planned $0.0M Jan 5

MAZE Sold 4,432 shares at $40.43 · planned $0.2M Jan 2

MAZE Sold 45,000 shares at $40.57 · planned $1.8M Dec 29

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.